Workup for Hand, Foot, and Mouth Disease in a 12-Month-Old
Hand, foot, and mouth disease (HFMD) in a 12-month-old is a clinical diagnosis that does not require laboratory testing in typical cases—diagnosis is based on the characteristic presentation of fever, oral ulcers, and rash on hands/feet/buttocks.
Clinical Diagnosis Approach
The diagnosis is straightforward when you see:
- Fever (present in 100% of cases) 1
- Painful oral ulcers (80.5% painful, 19.5% painless) 1
- Characteristic rash on hands (100%), feet (90.8%), knees (82.8%), and buttocks (79.3%) 1
- The rash is typically painful (74.7%) and/or itchy (73.6%) 1
Most cases are mild, self-limiting, and resolve within 7-10 days without sequelae 2. Treatment is symptomatic and supportive 2, 3.
When Laboratory Testing IS Indicated
You should obtain laboratory specimens only if:
1. Severe or Complicated Disease Features
Watch for these red flags that signal potential deterioration 3:
- Persistent high fever despite treatment
- Neurological involvement (altered consciousness, convulsions, meningeal signs)
- Worsening respiratory rate/rhythm
- Circulatory dysfunction
- Elevated peripheral WBC count
- Elevated blood glucose or lactic acid
2. Atypical Presentations
- Extensive or unusual rash distribution 4
- Absence of classic triad (fever, oral lesions, extremity rash)
- Suspected alternative diagnosis
Laboratory Workup When Needed
If testing is warranted, collect these specimens 5:
Primary Samples (in order of priority):
- Vesicle fluid (highest viral load, most diagnostic)
- Throat swab or respiratory sample
- Stool sample
The diagnostic method is RT-PCR targeting enterovirus 5. In one study, 89.7% of clinically diagnosed HFMD cases were RT-PCR positive, with Coxsackievirus A6 being the predominant strain (86.2%) 1.
For Severe Cases with Neurological Complications:
- CSF analysis if meningitis/encephalitis suspected 5
- Blood sample (baseline before any immunoglobulin administration) 5
- Respiratory specimen (essential for EV-D68 detection, which rarely appears in CSF) 5
Age-Specific Considerations for 12-Month-Olds
At 12 months, this child falls into the high-risk category (children <3 years with EV-A71 infection have worse outcomes) 3. However, the 1 month-1 year age group typically shows 6:
- Highest peripheral WBC and lymphocyte counts
- Lower rates of severe neurological complications compared to older toddlers
- Generally benign course
Convulsions are more common in the 1-3 year age group (21.48%), so your 12-month-old is at the younger edge of this risk 6.
Critical Pitfalls to Avoid
Don't confuse prolonged viral shedding with active disease: Enteroviruses colonize throat and gut for weeks to months, so positive throat/stool samples must be interpreted cautiously in the context of clinical presentation 5.
Don't miss EV-A71 cases: These cause more severe disease with higher complication rates than Coxsackievirus A16 2. Children <3 years with disease duration <3 days require closer monitoring 3.
Don't delay recognition of stage progression: The key is identifying stages 2 and 3 early to prevent progression to stage 4 (cardiopulmonary failure) 3.
Management Summary
For typical HFMD in your 12-month-old:
- Isolate to prevent transmission 3
- Symptomatic treatment (fever control, pain management)
- Outpatient management is appropriate 3
- Fever typically resolves within 5 days (58.6% of cases), rash within 7 days (68.8%), and oral ulcers within 5-7 days (51.8%) 1
Admit for observation if any red flag features develop 3.